These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10326745)

  • 1. Enhanced effects of monoclonal antibody carboplatin immunoconjugates uptake and anti-tumor effects with angiotensin II and tumor necrosis factor.
    Takeda A; Miyoshi T; Shimada H; Ochiai T; Isono K
    J Chemother; 1999 Apr; 11(2):137-43. PubMed ID: 10326745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of an antibody-enzyme conjugate for antibody-directed enzyme prodrug therapy in nude mice bearing a human colon adenocarcinoma xenograft.
    Stribbling SM; Martin J; Pedley RB; Boden JA; Sharma SK; Springer CJ
    Cancer Chemother Pharmacol; 1997; 40(4):277-84. PubMed ID: 9225945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability.
    Folli S; Pèlegrin A; Chalandon Y; Yao X; Buchegger F; Lienard D; Lejeune F; Mach JP
    Int J Cancer; 1993 Mar; 53(5):829-36. PubMed ID: 8449608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II.
    Noguchi A; Takahashi T; Yamaguchi T; Kitamura K; Noguchi A; Tsurumi H; Takashina K; Maeda H
    Jpn J Cancer Res; 1992 Mar; 83(3):240-3. PubMed ID: 1582884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent distension and enhanced diffusive extravasation of tumor vessels improved uniform tumor targeting of radioimmunoconjugate in mice administered with angiotensin II and kininase inhibitor.
    Kinuya S; Yokoyama K; Yamamoto W; Kawashima A; Konishi S; Hiramatsu T; Tega H; Shuke N; Aburano T; Watanabe N; Takayama T; Michigishi T; Tonami N
    Oncol Res; 1998; 10(11-12):551-9. PubMed ID: 10367936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors.
    Khawli LA; Miller GK; Epstein AL
    Cancer; 1994 Feb; 73(3 Suppl):824-31. PubMed ID: 8306266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of tumor vascular shutdown induced by 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Increased tumor vascular permeability.
    Zhao L; Ching LM; Kestell P; Kelland LR; Baguley BC
    Int J Cancer; 2005 Aug; 116(2):322-6. PubMed ID: 15800918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.
    Rowlinson-Busza G; Maraveyas A; Epenetos AA
    Br J Cancer; 1995 Apr; 71(4):660-5. PubMed ID: 7710925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualizing the acute effects of vascular-targeted therapy in vivo using intravital microscopy and magnetic resonance imaging: correlation with endothelial apoptosis, cytokine induction, and treatment outcome.
    Seshadri M; Spernyak JA; Maiery PG; Cheney RT; Mazurchuk R; Bellnier DA
    Neoplasia; 2007 Feb; 9(2):128-35. PubMed ID: 17356709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pre-irradiation on radiopharmaceutical localization in human colon tumor xenografts using mono- and bispecific monoclonal antibodies.
    Gridley DS; Slater JB; Mackensen DG; Slater JM
    Anticancer Res; 1996; 16(6B):3453-8. PubMed ID: 9042206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
    Sharkey RM; Karacay H; Griffiths GL; Behr TM; Blumenthal RD; Mattes MJ; Hansen HJ; Goldenberg DM
    Bioconjug Chem; 1997; 8(4):595-604. PubMed ID: 9258460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation.
    Kalofonos H; Rowlinson G; Epenetos AA
    Cancer Res; 1990 Jan; 50(1):159-63. PubMed ID: 2403414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enhancement of radiolabeled monoclonal antibody uptake with angiotensin II and tumor necrosis factor (TNF): preliminary report].
    Takeda A; Kikuchi T; Ozaki M; Ariga T; Nagashima T; Isono K; Miyoshi T
    Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):475. PubMed ID: 1870580
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C; Gafner V; Villani ME; Borsi L; Berndt A; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2003 Jun; 63(12):3202-10. PubMed ID: 12810649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248).
    Mosure KW; Henderson AJ; Klunk LJ; Knipe JO
    Cancer Chemother Pharmacol; 1997; 40(3):251-8. PubMed ID: 9219510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting colon cancer cells with genistein-17.1A immunoconjugate.
    Gentile MS; Vasu C; Green A; Murillo G; Das Gupta TK; Constantinou AI; Prabhakar BS; Salti GI
    Int J Oncol; 2003 May; 22(5):955-9. PubMed ID: 12684659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate.
    LeBerthon B; Khawli LA; Alauddin M; Miller GK; Charak BS; Mazumder A; Epstein AL
    Cancer Res; 1991 May; 51(10):2694-8. PubMed ID: 2021947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice.
    Ching LM; Goldsmith D; Joseph WR; Körner H; Sedgwick JD; Baguley BC
    Cancer Res; 1999 Jul; 59(14):3304-7. PubMed ID: 10416582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.
    Pedley RB; Hill SA; Boxer GM; Flynn AA; Boden R; Watson R; Dearling J; Chaplin DJ; Begent RH
    Cancer Res; 2001 Jun; 61(12):4716-22. PubMed ID: 11406542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
    Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
    Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.